ly 171883 has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
LY 171883: structure in first source; leukotriene receptor antagonist
tomelukast : A member of the class of acetophenones that is 1-phenylethanone substituted at position 2 by a hydroxy group, a propyl group at position 3 and a 4-(1H-tetrazol-5-yl)butoxy group at position 4. A leukotriene antagonist, it exhibits anti-asthmatic activity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drost, AC | 1 |
| Seitz, G | 1 |
| Boehmler, A | 1 |
| Funk, M | 1 |
| Norz, KP | 1 |
| Zipfel, A | 1 |
| Xue, X | 1 |
| Kanz, L | 1 |
| Möhle, R | 1 |
1 other study available for ly 171883 and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
The G protein-coupled receptor CysLT1 mediates chemokine-like effects and prolongs survival in chronic lymphocytic leukemia.
Topics: Acetophenones; Actins; Aged; Apoptosis; Blotting, Western; Calcium; Cell Line, Tumor; Cell Survival; | 2012 |